Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial
| Title: | Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial |
|---|---|
| Authors: | Diya, OyeniyiAff1; Gayed, JuleenAff1, IDs40121025011854_cor1; Lowry, Francine S.Aff2; Ma, HuaAff2; Bangad, VishvaAff2; Mensa, FedericoAff3; Zou, JingAff4; Xie, XupingAff4; Hu, YanpingAff4; Cutler, MarkAff5; Belanger, ToddAff5; Cooper, DavidAff5; Xu, XiaAff2; Mogg, RobinAff2; Türeci, ÖzlemAff3; Şahin, UǧurAff3; Swanson, Kena A.Aff5; Modjarrad, KayvonAff5; Anderson, Annaliesa S.Aff5; Gurtman, AlejandraAff5; Kitchin, NicholasAff1 |
| Source: | Infectious Diseases and Therapy. 14(8):1973-1987 |
| Database: | Springer Nature Journals |